A competency framework for clinical pharmacists and heart failure

The International Journal of Pharmacy Practice
Paul ForsythUnited Kingdom Clinical Pharmacy Association Heart Failure Group and the Royal Pharmaceutical Society

Abstract

Heart failure is an escalating 'pandemic' with malignant outcomes. Clinical pharmacist heart failure services have been developing for the past two decades. However, little clarity is available on the additional advanced knowledge, skills and experience needed for pharmacists to practice safely and competently. We aimed to provide an expert consensus on the minimum competencies necessary for clinical pharmacists to deliver appropriate care to patients with heart failure. There were four methodological parts; (1) establishing a project group from experts in the field; (2) review of the literature, including existing pharmacy competency frameworks in other specialities and previous heart failure curricula from other professions; (3) consensus building, including developing, reviewing and adapting the contents of the framework; and (4) write-up and dissemination to widen the impact of the project. The final framework defines minimum competencies relevant to heart failure for four different potential levels of specialism: all pharmacists regardless of role (Stage 1); all patient-facing clinical pharmacists (Stage 2); clinical pharmacists with specific planned roles in the care of heart failure patients (Stage 3); and regionally/nat...Continue Reading

References

May 30, 2001·European Journal of Heart Failure·S StewartJ J McMurray
Jul 27, 2005·British Journal of Clinical Pharmacology·A SadikJ C McElnay
Dec 13, 2005·Pharmacy World & Science : PWS·Alexander M ClarkMargaret E Reid
Feb 15, 2007·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·C López CabezasE Homs Peipoch
May 16, 2007·Annals of Internal Medicine·Michael D MurrayD Craig Brater
Aug 19, 2007·Heart·Arend Mosterd, Arno W Hoes
Jan 22, 2008·Journal of the American College of Cardiology·James B YoungUNKNOWN Heart Failure Society of America
Apr 17, 2008·Archives of Internal Medicine·Sheri L KoshmanRoss T Tsuyuki
Jun 9, 2009·Human Resources for Health·Claire AndersonAkemi Yonemura
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Feb 24, 2010·Circulation·Donald Lloyd-JonesUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jun 30, 2010·American Journal of Pharmaceutical Education·Charles H McDuffieSandra P Rogers
Feb 8, 2011·The American Journal of Medicine·Catherine Y WongHarlan M Krumholz
Nov 16, 2011·European Heart Journal·Richard LowrieUNKNOWN Heart Failure Optimal Outcomes from Pharmacy Study (HOOPS) Investigators
Aug 31, 2013·Circulation Research·Véronique L Roger
Oct 1, 2011·Pharmacy Practice·Jeffrey Atkinson, Bart Rombaut
Jan 28, 2014·European Journal of Heart Failure·Theresa A McDonaghStefan D Anker
Feb 5, 2014·Journal of the American College of Cardiology·Andrew P AmbrosyMihai Gheorghiade
Mar 10, 2016·BMJ : British Medical Journal·Melissa C BrouwersUNKNOWN AGREE Next Steps Consortium
May 26, 2016·European Journal of Heart Failure·Jillian P RileyStefan D Anker
Jul 13, 2016·Circulation·Robert L PageUNKNOWN American Heart Association Clinical Pharmacology and Heart Failure and Transplantation Committees of the Council on Clinical
Sep 1, 2014·ESC Heart Failure·Piotr PonikowskiGerasimos Filippatos
Jun 9, 2015·Pharmacy : Journal of Pharmacy, Education and Practice·Shane JacksonKay Sorimachi

❮ Previous
Next ❯

Citations

Oct 5, 2019·The International Journal of Pharmacy Practice·Anna RuebenAlison H Thomson
Mar 1, 2021·Research in Social & Administrative Pharmacy : RSAP·Arit UdohIan Bates
Apr 2, 2021·The International Journal of Pharmacy Practice·Clodagh ClarkePaul Forsyth
Jul 13, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Nikki GilluleyBen Elliott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved